5554 Federal Register / Vol. 69, No. 24 / Thursday, February 5, 2004 / Notices 

ESTIMATE OF ANNUAL HOUR BURDEN

Type of response Number of respondents 

Frequency of 

response 

Average time 

per response 

Annual hour 

burden 

Morbidity & Mortality AFU 3rd party next-of-kin .............................................. 300 1 0.5 150

Morbidity & Mortality AFU 3rd party Physicians .............................................. 300 1 0.5 150

Total .......................................................................................................... 600 ........................ ........................ 300

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, New Executive 

Office Building, Room 10235, 

Washington, DC 20503, Attention: Desk 

Officer for NIH. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact: Ms. 

Cheryl Nelson, NIH, NHLBI, 6701 

Rockledge Drive, MSC 7934, Bethesda, 

MD 20892–7934, or call non-toll-free 

number (301) 435–0707 or E-mail your 

request, including your address to: 

NelsonCH@nhlbi.nih.gov.

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication.

Dated: January 30, 2004. 

Peter Savage, 

Director, DECA, NH.

[FR Doc. 04–2388 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–10–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

H—Clinical Groups. 

Date: March 22, 2004. 

Time: 7:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Crystal City, 2899 

Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: Deborah R. Jaffe, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, National 

Cancer Institute, Division of Extramural 

Activities, 6116 Executive Blvd., Rm 8135, 

Bethesda, MD 20892, (301) 496–7721, 

jaffed@mail.nih.gov.

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: January 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2376 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Alternative Medicine; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Loan Repayment. 

Date: March 4–5, 2004. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Carol Pontzer, PhD, 

Scientific Review Administrator, National 

Center for Complementary, and Alternative 

Medicine, 6707 Democracy Blvd., Bethesda, 

MD 20892.

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Training and 

Education. 

Date: March 4–5, 2004. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Carol Pontzer, PhD, 

Scientific Review Administrator, National 

Center for Complementary, and Alternative 

Medicine, 6707 Democracy Blvd., Bethesda, 

MD 20892.

Federal Register / Vol. 69, No. 24 / Thursday, February 5, 2004 / Notices 5555

Dated: January 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2371 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary 

and Alternative Medicine 

Announcement of Strategic Planning 

Stakeholder Forums

ACTION: Notice.

SUMMARY: The National Center for 

Complementary and Alternative 

Medicine (NCCAM) is developing its 5-

year strategic plan (2005–2009), and 

invites the public to provide input 

regarding NCCAM research, training, 

outreach, and integration. Two strategic 

planning stakeholder forums will be 

held (March 22, 2004 in Bethesda, 

Maryland and April 19, 2004 in Seattle, 

Washington). In addition, the public is 

invited to provide comments via the 

NCCAM Web site. 

Background 

The National Center for 

Complementary and Alternative 

Medicine (NCCAM) was established in 

1999 with the mission of exploring 

complementary and alternative healing 

practices in the context of rigorous 

science, training CAM researchers, and 

disseminating authoritative information 

to the public and professionals. 

To date, NCCAM’s efforts to 

rigorously study CAM, to train CAM 

researchers, to conduct outreach, and to 

facilitate integration have been guided 

by NCCAM’s current strategic plan, 

‘‘Expanding Horizons of Healthcare: 

Five Year Strategic Plan 2001–2005’’

located on the NCCAM Web site at 

http://nccam.nih.gov/about/plans/

fiveyear/index.htm. Since its inception, 

NCCAM has funded over 300 projects 

and has over 700 grantee publications. 

NCCAM’s new strategic plan will also 

stipulate strategic goals, and will outline 

a research agenda that prioritizes among 

and between CAM domains, scientific 

area, and health conditions, based on 

identified needs and opportunities. 

Request for Comments 

The public is invited to provide input 

into the development of NCCAM’s 

strategic plan for 2005–2009. 

NCCAM will host two Strategic 

Planning Stakeholder Forums. These 

events will give NCCAM stakeholders 

an opportunity to voice their opinions 

regarding future directions for research, 

training, outreach, and integration in 

complementary and alternative 

medicine (CAM). The forums will be 

held:

March 22, 2004, 1 p.m. to 4 p.m., 

Natcher Conference Center, National 

Institutes of Health, Bethesda, 

Maryland 20892. 

April 19, 2004, 1 p.m. to 4 p.m., The 

Westin Seattle, 1900 Fifth Avenue, 

Seattle, Washington 98101.

Forum attendees are welcome to 

address a listening panel composed of 

NCCAM senior staff and National 

Advisory Council members. Remarks 

should be limited to 3 minutes per 

speaker. Those wishing to address the 

panel should register to attend at least 

5 days prior to their selected forum. 

NCCAM will schedule speakers until 

the time allotted is filled. To register, 

please visit http://nccam.nih.gov. 

Alternatively, the public is invited to 

submit written testimony via this Web 

site.

FOR FURTHER INFORMATION CONTACT: To 

request more information, visit the 

NCCAM Web site at http://

nccam.nih.gov, call 1–888–644–6226, or 

e-mail info@nccam.gov. 

Comments Due Date 

Comments regarding the development 

of NCCAM’s strategic plan are best 

assured of having their full effect if 

received by April 20, 2004.

Dated: January 29, 2004. 

Christy Thomsen, 

Director, Office of Communications and 

Public Liaison, National Center for 

Complementary and Alternative Medicine, 

National Institutes of Health.

[FR Doc. 04–2390 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; Review of Conference 

Grants (R13s). 

Date: March 16, 2004. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIEHS/National Institutes of Health, 

Building 4401, East Campus, 79 T.W. 

Alexander Drive, EC 122, Research Triangle 

Park, NC 27709, (Telephone Conference 

Call). 

Contact Person: RoseAnne M. McGee, 

Associate Scientific Review Administrator, 

Scientific Review Branch, Office of Program 

Operations, Division of Extramural Research 

and Training, Nat. Inst. of Environmental 

Health Sciences, P.O. Box 12233, MD EC–30, 

Research Triangle Park, NC 27709, (919) 541–

0752.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: January 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2369 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant